NCT06213298 2026-02-11
Effect of Kava on Anxiety and Stress in Cancer Survivors
Masonic Cancer Center, University of Minnesota
Phase EARLY_PHASE1 Suspended
Clinical Trials
10 trialsNCT06665568 2025-05-01
Keta-Care
University of Zurich
Phase EARLY_PHASE1 Not yet recruiting
NCT06001372 2025-04-16
TREK
University of Utah
Phase EARLY_PHASE1 Terminated
NCT02415387 2024-07-24
IMPACT
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT00737399 2024-04-16
Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)
Soul Medicine Institute
Phase EARLY_PHASE1 Active not recruiting
NCT05344625 2024-01-24
KAPTIVATED
Northwell Health
Phase EARLY_PHASE1 Withdrawn
NCT00957359 2020-10-20
Psilocybin Cancer Anxiety Study
NYU Langone Health
Phase EARLY_PHASE1 Completed
NCT01633008 2019-09-30
Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT02442739 2018-11-06
Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT02836288 2018-11-06
Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed